ACTIVE

Le Conseil International des Excipients Pharmaceutiques - Europe

Financial year 2025 · Closed on 31/12/2025

Net result35,1 k €-63,1 %over 1 year

Gross margin413 k €+4,0 %over 1 year

Equity1,2 M €+3,1 %over 1 year

Identity

Source · BCE/KBO

Le Conseil International des Excipients Pharmaceutiques - Europe is a Non-profit organization incorporated in 2012. Its main activity is: Management consultancy activities. Its registered office is in Bruxelles.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0501.816.137
Incorporation: 07/12/2012
Legal form: Non-profit organization
Registered office: Rue Marie de Bourgogne 52 box 2
1000 Bruxelles · BruxellesSee on map
Latest accounts: 31/12/2025

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities 94110Activities of business and employers membership organisations 94110Activities of business and employers membership organisations

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 6 filings

Trend over 6 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	413 k €	+4.0%	397,3 k €	-0.7%	399,9 k €	+12.2%	356,4 k €	+8.6%	328,1 k €
EBITDA	34,5 k €	-62.4%	91,6 k €	+32.4%	69,1 k €	+1002%	-7,7 k €	-417%	2,4 k €
Operating result	28,3 k €	-68.4%	89,3 k €	+33.3%	67 k €	+974%	-7,7 k €	-417%	2,4 k €
Net result	35,1 k €	-63.1%	95,2 k €	+48.6%	64 k €	+721%	-10,3 k €	-4243%	248,8 €
Balance sheet
Equity	1,2 M €	+3.1%	1,1 M €	+9.0%	1,1 M €	+6.5%	987,9 k €	-1.0%	998,2 k €
Total assets	1,3 M €	+3.3%	1,2 M €	+8.6%	1,1 M €	+6.7%	1,1 M €	+0.4%	1,1 M €
Cash	672 k €	+12.6%	596,6 k €	-13.1%	686,3 k €	-14.2%	799,8 k €	-24.0%	1,1 M €
Debts	69,7 k €	+6.6%	65,4 k €	-9.5%	72,2 k €	-5.1%	76,1 k €	+23.1%	61,8 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

7 active · 4 ended

Active mandates

Director	Mandates in this company	Period
Frank Milek	DirectorVice-chairman of the board of directorsended
Jesus Javier Rivas Garrido	Director
Karine Aranzana Roth	Chairman of the board of directorsVice-chairman of the board of directorsended
Karsten Diehl	Administrateur / TrésorierDirectorended
Kevin Hughes	Vice-chairman of the board of directorsDirectorended
Lotte Kok	Director
Mahmud Yunis	Director

Ended mandates

Director	Mandates in this company	Period
Amina Faham	Chairman of the board of directors
Elizabeth Meehan	Director
Frithjof Holtz	Chairman of the board of directors
Karine Aranzana	Vice-chairman of the board of directors

Other companies at this address

Rue Marie de Bourgogne 52 1000 Bruxelles

Company	CBE no.
EUROCITY● Active	0443.034.137
Eurocity Holdings● Active	0525.698.230
EXCiPACT● Active	0545.771.884
FEDERATION EUROPEENNE DE L'INDUSTRIE DU SPORT● Active	0470.117.032
La Fédération du Conseil International des Excipients Pharmaceutiques● Active	0823.931.361
Stichting Wereld Dorpen voor Kinderen● Active	0448.127.330
UTOPIA LAB BRUXELLES● Active	0727.824.949

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/06/2026	13/10/2025	05/06/2024	30/09/2023	15/12/2022	03/09/2021
General meeting	04/02/2026	05/02/2025	07/02/2024	15/03/2023	22/06/2022	03/02/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 6 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	04/02/2026	02/06/2026	French	PDF
Micro model	31/12/2024	05/02/2025	13/10/2025	French	PDF
Micro model	31/12/2023	07/02/2024	05/06/2024	French	PDF
Micro model	31/12/2022	15/03/2023	30/09/2023	French	PDF
Micro model	31/12/2021	22/06/2022	15/12/2022	French	PDF
Micro model	31/12/2020	03/02/2021	03/09/2021	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

7 active · 4 ended

Active mandates

Director	Mandates in this company	Period
Frank Milek	DirectorVice-chairman of the board of directorsended
Jesus Javier Rivas Garrido	Director
Karine Aranzana Roth	Chairman of the board of directorsVice-chairman of the board of directorsended
Karsten Diehl	Administrateur / TrésorierDirectorended
Kevin Hughes	Vice-chairman of the board of directorsDirectorended
Lotte Kok	Director
Mahmud Yunis	Director

Ended mandates

Director	Mandates in this company	Period
Amina Faham	Chairman of the board of directors
Elizabeth Meehan	Director
Frithjof Holtz	Chairman of the board of directors
Karine Aranzana	Vice-chairman of the board of directors

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates15/06/2026
DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates16/07/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates07/10/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates27/06/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates31/01/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates19/09/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates23/03/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates03/05/2021
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings6 filings

201220132014201520162017201820192020202120222023202420252026

IPEC EUROPE

Rue Marie de Bourgogne 52 bte 2, 1000 Brussels

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue Marie de Bourgogne 52 bte 2, 1000 BrusselsCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00141089

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Le Conseil International des Excipients Pharmaceutiques - EuropeCurrent		CBE
IPEC EUROPE	accounts 2021 → 2025	Accounts 2025 · 2026-00141089

Events

2025
Annual accounts 202535,1 k €↓
2024
Annual accounts 202495,2 k €↑
2023
Annual accounts 202364 k €↑
2022
Annual accounts 2022-10,3 k €↓
2021
Annual accounts 2021248,8 €↓
2020
Annual accounts 202069 k €
07/12/2012
IncorporationNon-profit organization

Le Conseil International des Excipients Pharmaceutiques - Europe

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events